Literature DB >> 9915631

Effects of clonidine on power spectral analysis of heart rate variability in mild essential hypertension.

C Lazzeri1, G La Villa, M Mannelli, L Janni, G Barletta, N Montano, F Franchi.   

Abstract

Patients with essential hypertension often show alterations of the autonomic nervous system. We evaluated the sympathetic and parasympathetic drive to the heart in 12 mildly hypertensive patients and 9 healthy subjects by power spectral analysis of heart rate variability. All subjects underwent measurements of RR interval, low (LF) and high frequency (HF) components of heart rate variability, LF/HF ratio and blood pressure in the resting and sitting positions, both before and after oral clonidine (300 microg), a central sympatholytic agent. In the supine position before clonidine, hypertensive patients had higher blood pressure and lower HF values than healthy subjects. Clonidine induced increases in RR interval and HF in both groups, while LF and LF/HF ratio decreased in healthy subjects, but not in hypertensive patients. On assuming the sitting position, both groups showed reductions in RR and HF and increments in LF and LF/HF. In healthy subjects, the response to the postural challenge was unaffected by clonidine. In contrast, hypertensive patients showed no changes in LF and LF/HF ratio, and a significantly lower decrease in HF. These differences were probably due to the existence of two subsets of patients, one exhibiting similar responses to clonidine as healthy subjects, and the other showing no appreciable response to the drug. These results suggest that hypertensive patients have an altered sympatho-vagal balance to the heart, which can be unmasked by clonidine. This phenomenon should be taken into account to achieve a better control of the overall cardiovascular risk of hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9915631     DOI: 10.1016/s0165-1838(98)00148-9

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  2 in total

1.  Transdermal neuromodulation of noradrenergic activity suppresses psychophysiological and biochemical stress responses in humans.

Authors:  William J Tyler; Alyssa M Boasso; Hailey M Mortimore; Rhonda S Silva; Jonathan D Charlesworth; Michelle A Marlin; Kirsten Aebersold; Linh Aven; Daniel Z Wetmore; Sumon K Pal
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

2.  Effects of low-dose clonidine on cardiovascular and autonomic variables in adolescents with chronic fatigue: a randomized controlled trial.

Authors:  Even Fagermoen; Dag Sulheim; Anette Winger; Anders M Andersen; Johannes Gjerstad; Kristin Godang; Peter C Rowe; J Philip Saul; Eva Skovlund; Vegard Bruun Wyller
Journal:  BMC Pediatr       Date:  2015-09-10       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.